The funding may be modest but the backers of CellCAN have ambitious plans for advancing the use of stem cell therapy in personalized medicine. Spun off from the Stem Cell Network (SCN) — a traditional Network of Centres of Excellence (NCE) due to sunset next year — CellCAN leverages the significant investments made in stem cell research by linking cell manufacturing centres with several with other key players in the stem cell research ecosystem.